Defra has confirmed that equine infectious anaemia (EIA) has been detected in two horses in Wiltshire following importation from Romania via Belgium.
The premises is currently under restriction and the two infected horses will be humanely destroyed in line with existing regulations. The other horses on the premises will be subject to epidemiological investigation in the coming weeks. A further two horses have also been under investigation and test results have proved negative.
The animals arrived in a group of 10 horses, nine of which originated from Romania and one from Belgium. The nine Romanian horses were tested for EIA as part of routine post-import testing. Seven horses all tested negative. The horse that originated in Belgium is due to be tested shortly.
Chief Veterinary Officer, Nigel Gibbens said: "This is the first case of equine infectious anaemia infected animals being imported into Great Britain since 1976 and shows the success of our post import testing regime. These were apparently healthy horses carrying a notifiable disease that we are keen to keep out of Great Britain. After considering the risk I have decided to take appropriate action and humanely destroy these two horses that tested positive."
Global names in gastroenterology will be sharing the latest knowledge to help veterinary surgeons and nurses support the work of the BHS and Nottingham University’s REACT to colic campaign, which is designed to help vets and horse owners work together for colic patients.
On Friday 13th September there'll be a two-hour session chaired by Harry Carslake, a diplomate of the American College of Veterinary internal medicine (ACVIM). The session will involve five experts speaking about aspects of colic, followed by discussion and the opportunity for questions from delegates.
Natasha Jocelyn, Internal Medicine Specialist, Sussex Equine Hospital, will speak about managing the acute colic in the field: what to do when flunixin doesn’t work.
Prof. Dr. Gunther Van Loon European Veterinary Specialist in Equine Internal Medicine, Ghent University, Belgium, will discuss managing acute colic in the equine hospital.
Dr Nathan Slovis member of the American College of Internal Veterinary Medicine, Director of the McGee Medicine Department and a partner at Haygard Equine Medical Institute in Lexington, Ky will explain colic guidelines – can ‘algorithms’ help?
Prof. Dr Lutz Goehring European Veterinary Specialist in Equine Internal Medicine, Ludwig-Maximilians University Munich, will explore the question ‘is there an evidence-based approach to managing enteritis?’
David Rendle European Veterinary Specialist in Equine Internal Medicine, Rainbow Equine Hospital, North Yorkshire, will look at parasitic disease as a cause of colic and methods of management.
All BEVA Congress delegates get a certificate of attendance worth seven hours of CPD.
If you're struggling for time or torn between several lectures you can use the BEVA Congress Encore Room to play back missed lectures at your convenience. BEVA Congress is also providing day crèche for children between the ages of 0-8 years. Find out more here.
Anyone who registers for Congress before 8 May 2019 will receive significantly reduced booking fees, and BEVA members save up to £379 on their Congress passes.
Consistent with previous surveys, lameness was shown to be more likely to be caused by conditions such as osteoarthritis in the limb rather than problems in the foot.
Blue Cross carries out NEHS in May each year in partnership with the British Equine Veterinary Association (BEVA). It is sponsored by Dodson & Horrell and Zoetis and supported by the UK’s leading equestrian organisations and charities.
This year saw a 14% increase in participation compared to 2015, with survey records returned for almost 16,751 horses, ponies, donkeys and mules and 5635 people taking part. Most horses were kept in livery or a private yard and used for leisure and hacking.
Lameness has been consistently seen as the most common syndrome affecting horses in the NEHS results year on year. In the latest survey a total of 32.9% (24.4% in 2015) of horses and ponies with health problems were recorded as lame. Overall, as in previous years, lameness in the limb was more common than lameness caused by problems in the foot.
A breakdown of the types of lameness revealed that 47.4% were recorded as suffering from proximal limb lameness, 31.9% from causes of foot lameness other than laminitis and 20.7% from laminitis. Degenerative joint disease (including foot and proximal limb) was the most frequently reported single cause of lameness (41.2% of all lameness) and the most frequently reported joint affected by DJD was the hock (15.3% of all lameness).
Reports of foot lameness (excluding laminitis) more than doubled this year at 10.5% (4.5% in 2015) of all syndromes reported with pus in the foot being the most frequently recorded problem. This could possibly be attributed to the persistent wet weather during and prior to the survey, which can increase susceptibility to the condition.
Josh Slater from the Royal Veterinary College, who is a member of BEVA’s Health & Medicines Committee and analysed the NEHS data, said: "The data gleaned from the survey remains consistent year on year, confirming the reliability of our findings for benchmarking, referencing and research. This year’s increase in overall lameness may be in part attributed to the higher incidence of pus in the foot but may also be because owners are becoming more aware of lameness issues. Ongoing research on lameness has generated significant media coverage over the past year, helping to raise understanding of the importance of accurate diagnosis and treatment both from welfare and performance perspectives."
The six most notable disease syndromes identified in the 2016 National Equine Health Survey are:
Gemma Taylor, Education Officer at Blue Cross said: "The significant increase in participation again this year shows that owners and keepers of horses are really getting behind the survey and recognising its importance in safeguarding the future health and of the UK’s horses. Over the past year NEHS data has been referred to in leading equestrian and veterinary media, showing its credibility as a valuable benchmarking reference."
The 2016 NEHS survey results are now available. To download a copy visit http://www.bluecross.org.uk/nehs2016results and to register for next year’s survey please visit www.bluecross.org.uk/nehs
Their study, which was published in the research journal PeerJ at the end of last year1, investigated the effects of insulin on equine hoof lamellar cells in the laboratory.
The researchers say that high levels of insulin have been known for some time to cause acute endocrine laminitis, seen when ponies and certain types of horses graze lush pasture or consume a starch- or sugar-rich diet, or when they develop Cushing’s syndrome.
Many ponies and horses at risk of the condition produce large spikes of insulin in their blood stream after consuming meals high in non-structural carbohydrates (in particular starch and simple sugars) which indicates that this could be the way in which they succumb to acute endocrine laminitis.
The mechanism by which insulin can cause effects in the foot leading to laminitis has been the subject of much debate in recent years.
Hormones like insulin must interact with a specific receptor on the surface of cells in order to produce their effects. What has confused researchers in the past is that there appear to be no insulin receptors on the hoof lamellar cells (these cells give the lamellar tissues their strength and changes to their growth or structure weaken the bonds and cause laminitis).
The researchers considered the close similarities between insulin and a growth factor hormone called insulin-like growth factor -1 (IGF-1). There are receptors for IGF-1 on the lamellar cells, and the researchers speculated that high concentrations of insulin might be able to cross-stimulate these cells by activating the IGF-1 receptors. To investigate this possibility PhD student Courtnay Baskerville, together with her supervisor Professor Simon Bailey, developed a method for culturing lamellar epithelial cells in the laboratory, and incubated them with increasing concentrations of insulin.
They found that high concentrations of insulin stimulated the cells to proliferate. Furthermore, this effect could be prevented using an antibody that specifically blocks only the IGF-1 receptor. Further downstream effects within the cells were also shown. The changes seemed to occur mainly at very high concentrations of insulin. Similar concentration levels can be seen in ponies and horses with insulin dysregulation linked to Equine Metabolic Syndrome, but are not commonly seen in normal horses that are considered to be at lower risk of laminitis.
Further work is now ongoing to determine exactly how these cellular changes induced by sustained high insulin concentrations might cause laminitis. However, it seems that targeting the IGF-1 receptor may be an option for developing new drugs to prevent and treat laminitis.
Professor Simon Bailey said: "The information gathered in this study provides the equine industry worldwide with valuable insights into the causes of the common and serious condition of laminitis. The research group would like to acknowledge the support of the Waltham Centre for Pet Nutrition, in particular the involvement of Professor Pat Harris.”
Reference
The company says the new test overcomes a major shortcoming in faecal egg counts: that they can only detect the presence of egg-laying adult worms. The new test, by contrast, can detect all stages of the small redworm life cycle, including the important encysted larval phase.
ADB says the new test will help protect the effectiveness of moxidectin, the only dewormer which is capable of eliminating the encysted stages and against which widespread resistance is not thought to have developed.
Whereas before, routine winter treatment was needed to target the encysted phase, this new test means the drug can be kept for when it is really needed, which will help prevent the development of resistance. ADB says it will also be of great value to equine vets in making differential diagnoses.
The blood test was developed by Prof Jacqui Matthews’ group at the Moredun Research Institute (MRI), with funding from The Horse Trust. She said: "It is great to see the commercialisation of this much-needed test to support sustainable worm control in horses. The test fills an important gap in our diagnostic toolbox and will enable horse owners to work with their veterinarians in targeting anthelmintic treatments against cyathostomin infections and hence help protect these important medicines for the future."
Dr Corrine Austin from ADB said: "ADB is now developing laboratory ELISA kits to enable independent veterinary laboratories to conduct blood testing; these kits are expected to reach market during 2020. Research into the saliva-based test is ongoing and is expected to be commercialised several years from now."
Veterinary practices can contact ADB at info@austindavis.co.uk to register interest in the diagnostic test service.
The vaccine will be available to order directly from Merial on receipt of a Special Import Certificate (SIC) issued by the VMD to the named vet. The SIC is only required once but needs to accommodate all potential doses required, enabling Merial to supply to direct orders from the practice.
The product is available in 10 dose packs at a net price of £89.00 per pack.
For further information, contact Merial Customer Support Centre (UK) on 0870 6000 123 or your local equine territory manager.
Equine obesity is a growing problem not just in the UK but around the world. The debate explored how various sectors of the equestrian industry see the challenges faced by people who are struggling to manage their horse’s weight. It included the views of equine vet Lucy Grieve, horse owner Helen Gale, livery yard owner and coach Beth Maloney, nutritionist Liz Bulbrook, competition judge David Ingle and equine welfare officer Penny Baker.
The session was chaired by equine vet and nutrition specialist Professor Pat Harris with the support of Dr Tamzin Furtado, a social scientist with a special interest in human behaviour change for animals.
The panellists shared their views on what they believed to be the blocks for horse owners in recognising obesity and addressing the problem.
They identified the importance of empowering owners and working with them to make step by step changes with the support of a reliable and trusted team including vet, nutritionist, yard owner and farrier.
Lucy said: “Vets are in unique and privileged position to provide an achievable and effective tailor-made strategy for individual horses.
"We must all learn to overcome avoidance and engage recognise, accept and understand, and tailor a solution.”
Helen added: “Owners need to be able to recognise and acknowledge that their horse has a weight problem and be motivated to take action. Communication is key. It’s important for others to understand why you are following the advice form vets and other experts and how they can best help."
There was recognition that a bespoke approach is needed for every horse, owner and situation. Some livery owners may face challenges in changing management practices and peer pressure on a yard may prevent people implementing intake restriction measures such as a grazing muzzle or restricted turnout.
Beth said: “Peer pressure can be daunting and there can be a lack of confidence that you are doing the right thing."
Communication and proactive signposting to reliable advice and scientific information were identified as pivotal, not only in helping to identify weight changes but also to build horse owners’ knowledge and confidence. This would build a clearer understanding of the calorific value of feeds and of grass and forage, what constitutes a balanced diet, the importance of regular exercise and weight monitoring, being able to identify the difference between fat and muscle and being familiar and comfortable with the range of weight control tactics, such as grazing muzzles, restricted grazing and track systems.
The language used was also identified as important; gauging the needs and response of the individual and asking the owner what they think, would be more effective than using potentially inflammatory language - for example choosing the phrase ‘fat pad’ rather than the terms ‘overweight’ or ‘obese’.
Lucy said: “If we are all being really honest with ourselves obesity is neglect. I doubt many vets would walk away from an emaciated horse or an infected wound or a cloudy eye so why are we so willing to walk away from these ticking time bombs which are actually a real welfare issue as the animal is potentially at risk of losing their life?”
You can buy tickets for a replay of the debate for £5, here: https://www.eventbrite.co.uk/e/the-great-weight-debate-equine-playback-tickets-138080533593
The 29th National Equine Forum will be held online on Thursday 4th March 2021. Tickets will be available in February 2021. If you'd like to be notified when they become available, you can subscribe here: https://www.nationalequineforum.com/subscribe/
The RCVS has announced that registrations for the new RCVS Register of Veterinary Practice Premises will be accepted from 1 November 2008, allowing all those who wish to supply medicines from veterinary practice premises from 1 April 2009 onwards a full five months to comply with the latest medicines legislation.
In order to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines, the UK Government decided that any veterinary surgeon may only supply veterinary medicinal products (VMPs) from premises registered with the Secretary of State, with effect from 1 April 2009.
The Veterinary Medicines Directorate (VMD) is responsible for the inspection and registration of practices under the Veterinary Medicines Regulations. Steve Dean, VMD's Chief Executive, says the new veterinary practice premises register will complete the UK information base by bringing veterinary practices in line with other suppliers of veterinary medicines who already have to operate from registered premises.
The Register will enable the supply of veterinary medicines by veterinary surgeons, including controlled drugs, to be subjected to inspection and verification. As a result, DEFRA Ministers and the European Commission can be re-assured that veterinary medicines are being supplied in the UK in accordance with EC legislation.
In discussion with the VMD, it was agreed that the most appropriate body to maintain this register would be the RCVS, not least because the College already manages the RCVS Practice Standards Scheme and publishes the (voluntary) Directory of Veterinary Practices, so has the necessary systems already in place. The register will be published on RCVSonline and updated quarterly.
Whilst there will now be a statutory fee levied for each practice premises registered on the new Register, the College's existing database framework has kept this to a relatively low £40 compared to what other bodies might have had to charge after starting from scratch.
Practices could appear in the Directory for free because the cost of producing it was partially covered by subsequent data sales. However, the new Register will need to be self-funding, as the data it contains will be freely available online.
Not all practices will have to pay the statutory fee. RCVS President Jill Nute said: "For those practice premises already accredited under the RCVS Practice Standards Scheme (PSS), the fee will be taken from their existing PSS annual fee.
"What's more, accredited practices will not face additional four-yearly inspections by VMD inspectors (unless there is an investigation for enforcement purposes) as their PSS inspections already ensure that they keep up to date with current medicines legislation."
Practice premises that have applied to join the Scheme, but have not yet been accredited, will not face additional VMD inspections either, but will still need to pay the statutory fee.
To help practices understand the new requirements and what they need to do before next April, the RCVS has produced a range of guidance, including a series of Frequently Asked Questions (www.rcvs.org.uk).
"In particular, we hope this guidance will help to explain which premises are likely to be considered ‘veterinary practice premises' and the difference between those premises and places where medicines might simply be stored or kept," said Mrs Nute.
"It is important to realise that there is a legal requirement to register veterinary practice premises for the supply of medicines, and a professional obligation, set out in the Guide to Professional Conduct, to keep a record of where all medicines are stored or kept. This record should avoid the need for additional registration of car boots, farms and homes."
Over the coming weeks, application forms will be posted to all practices currently listed in the Directory and accredited under the PSS, containing all the practice information currently held. These forms must be checked, signed and returned, even if no fee is due. Separate application forms will be available for any non-accredited practice premises not published in the Directory, and a letter will be sent to all RCVS members to ensure the whole profession is aware of the new requirements.
Vet Direct says the unit, which is used for the diagnosis and monitoring of anaemia in dogs, cats and horses, requires only a simple ear-prick test to deliver a result.
Leon Wright, managing director at Vet Direct, said: "The AniPoc device eliminates the need to draw blood with a syringe, a simple pin prick is enough, and is perfect for both veterinary practices and home visits.
"The speed and accuracy of the product means that it is better equipped to monitor animals undergoing anaesthesia or transfusions, and can be used to effectively screen animals taking part in Pet Blood Banks and mobile clinics."
Vet Direct says the AniPoc also delivers results much faster than a centrifuge and doesn’t require any time to be spent in the lab; a process which can take 10-20 minutes to get a result - by which time they are often out-of-date in critical cases.
The AniPoc Handheld Monitor and Starter Kit is available from Vet Direct for £250.
For more information, visit www.vet-direct.com or call 0800 068 3300.
Danilon is used to relieve the pain caused by musculoskeletal conditions, such as osteoarthritis (OA), bursitis, laminitis, and soft tissue inflammation.
Some oral NSAIDs have been shown to increase the risk of gastric irritation¹ - a particular concern when treating of chronic conditions.
However, Animalcare points to a study² in which horses given Danilon Gold showed a reduced number of ulcers and those that did appear were less severe.
The area of gastric mucosa affected was also five times less.
Animalcare says accurate administration is critical for clinical success.
To support this, Danilon Gold is presented in a coloured granule formulation and is now available in both 3g and 10g sachets.
References
The divestment is expected to be concluded in mid-2020, and Bayer intends to exit its stake in Elanco over time.
Bayer says that combining Elanco and Bayer Animal Health will create the number two animal heath company, with top three positions across a broad range of species and geographies. It also enhances Elanco’s portfolio of leading global brands and bolsters its innovation capabilities and R&D pipeline.
Jeffrey N. Simmons, president and chief executive officer of Elanco, said: "Combining Elanco’s strong relationship with veterinarians and Bayer’s leadership in retail and e-commerce will ultimately benefit all our customers. We look forward to joining our complementary portfolios and capabilities to build a fully focused animal health company, providing a sustained flow of innovation for farmers, veterinarians and pet owners."
The virtual collection provides a source of evidence to determine what is or is not of clinical significance in cardiac arrhythmia and what might represent the best course of action, if action is needed, within the requisite parameters of safety and welfare.
With an editorial written jointly by Peter Physick-Sheard and Joann Slack the virtual collection includes:
... and more.
Professor Celia Marr, Editor of the EVJ said: “In terms of day-to-day veterinary work, rhythm disturbances are a frequent frustration during prepurchase examinations or perceived poor performance assessments. This outstanding collection brings to hand the most recent evidence to help clinicians support their observations, facilitating diagnosis and a treatment plan in this challenging area.”
The Virtual issue can be downloaded here: https://beva.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)2042-3306.irregular-hearts-performance.vi
Dechra Veterinary Products has launched Buprenodale, an opioid analgesic for cats, dogs and horses presented in a 10ml multi-dose vial.
Carol Morgan, Brand Manager said: "Following on from the introduction of Comfortan and Anesketin, our Buprenodale Multidose, 0.3 mg/ml solution for injection for dogs, cats and horses, is the latest addition to the portfolio.
"The active substance in Buprenodale is buprenorphine, the most commonly used opioid analgesic in small animal practice in the UK.
"Buprenodale Multidose joins a portfolio of Dechra products covering a wide range of species, different levels of analgesic efficacy and duration of action.
"The product is now available in a 10 ml multidose vial. It is suitable for post-operative analgesia in dogs and cats; post operative analgesia, in combination with sedation, in horses and potentiation of the sedative effects of centrally acting agents in the dog and horse."
For more information www.dechra.co.uk .
Woodley Equipment Company has announced that Veterinary Parasep Faecal Filters are now available exclusively from the company.
According to the Woodley, the filters have been developed in conjunction with an independent leading veterinary Institution and offer an improved method of determining Worm Egg Counts (WEC) on cattle, sheep and horses. Flotation methods for WEC can require several Specific Gravity solutions to cover different parasites. The two common flotation methods, ‘Modified McMaster' and ‘Improved Modified McMaster', both use Saturated NaCL and are both catered for with Veterinary Parasep.
Woodley says the key advantages of the new filters are:
For a more information about The Veterinary Parasep please email sales@woodleyequipment.com or call the customer service team on +44 (0) 1204 669033 ~ Option 1.
Alternatively, visit http://www.woodleyequipment.com/.
Dechra Veterinary Products has launched Ketodale, an anti-inflammatory injection for cattle, horses and swine.
Ketodale contains the non-steroidal anti-inflammatory drug ketoprofen 100mg/ml. It is indicated for use in cattle and swine for diseases associated with inflammation, pain or fever. In cattle these include respiratory diseases, mastitis, osteoarticular and muscular-skeletal disorders, such as lameness and arthritis, and to ease pain post parturition. Ketodale can be used to treat swine suffering from Mastitis Metritis Agalactia (MMA) Syndrome and respiratory tract infections.
In horses, Ketodale is indicated for diseases affecting the osteoarticular and muscular-skeletal system associated with pain and inflammation. These include naviculitis, arthritis and laminitis. It can also be used for post-surgical inflammation and symptomatic therapy of colic and fever.
Ketodale is available in 50ml and 100ml vials.
To coincide with the product's launch, Dechra is carrying out a direct marketing campaign. Practices can take advantage of a special launch offer where they can purchase four vials and get a fifth free. The offer is available for a limited period only.
To find out more about Ketodale, call Dechra on 01743 441 632 or visiting www.dechra.com
Thus far, the hospital has relied on conventional radiographs or referred for MRI for the bulk of its distal limb imaging.
The new Hallmarq standing CT scanner provides information that surpasses the capabilities of radiography, while also reducing radiation exposure to the patients and staff.
The scanning process is also considerably quicker, enabling prompt diagnosis and treatment planning.
Tom McParland, Valley Equine Hospital’s surgeon said: "We are confident that this diagnostic modality will significantly enhance our ability to identify not just thoroughbred fetlock pathology earlier but improve our diagnostic abilities of the distal limb for all our equine patients, racing and leisure alike.”
Valley Equine Hospital says it chose the Hallmarq standing CT scanner due to its ability to scan using just standing sedation which ensures a safer and more efficient experience for the horses compared to general anaesthesia.
www.valleyequinehospital.co.ukinfo.hallmarq.net/focus-on-the-foot
Dechra Veterinary Products has launched a new 50 ml bottle of its rapid acting dissociative anaesthetic licensed for cats, dogs and horses, Anesketin.
Anesketin solution for injection, containing Ketamine 100 mg/ml, is indicated for induction of anaesthesia.
Dechra Brand Manager Craig Sankey said: "Anesketin has proved to be a very popular product in our range due to its versatility. It can be used in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction of anaesthesia.
"As it does not require any special temperature storage conditions it makes it a very portable product for vets on the move."
He added: "We are very pleased to be able to add the larger Anesketin product to our wide range of analgesics and sedatives. This demonstrates our commitment to offering high quality products that support vets in small animal and equine practice."
Dechra says the product can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required in cats.
Anesketin is also available in 10 ml vials. For further information, visit www.dechra.co.uk
Co-edited by Paddy Dixon and Vicki Nicholls, the collection comprises ten studies on physiology, disease, diagnosis and treatment techniques in equine dentistry. The editors say it gives veterinary surgeons free access to some of the most important current research in the UK.
The studies include:
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "Care of the horse’s teeth is fundamental to good health. To this end a strong working knowledge of equine dentistry should be seen as an essential cornerstone for every equine practitioner. This diverse collection has the convenience of being easily accessible, online and in one place to help keep vets fully abreast of the excellent research currently being conducted in the UK."
Vicki Nicholls, incoming president of BEVA, continued: "Advances in equine dentistry continue to gather pace and it has been a pleasure and privilege to work with Paddy Dixon collating the most current dental research that will be relevant to all equine practitioners with any level of expertise."
The equine dentistry collection is available free online at: http://bit.ly/2bBDuMW.
Defra has announced plans to form a new Animal Health and Welfare Board for England which will bring experts including farmers, veterinary surgeons, welfare experts and others from outside Government together with the Chief Veterinary Officer and civil servants to make direct policy recommendations on policy affecting the health and welfare of all kept animals such as farm animals, horses and pets.
According to Agriculture Minister Jim Paice, it is the first time that people affected by Government policy on animal health and welfare will make recommendations on those policies directly to Ministers.
Mr Paice said: "This is a completely new way of working. It replaces the old ways, where the people most affected by decisions were kept at arm's length from policy making on those subjects.
"This is about the Big Society not just existing in our communities, but in the heart of Government - helping to put the decisions in the hands of those who are doing the work on the ground.
"We've already seen the success of a partnership between farmers and the Government with the work that's been done on bluetongue - which has seen the disease virtually eradicated in this country."
Final decisions on animal health and welfare policy will remain in the hands of Government Ministers.
The Board will be made up of around 12 members, 5 senior Defra officials including the Chief Veterinary Officer, and 7-8 external members including the chair. The external members will have experience and knowledge of kept and farmed animals, animal and veterinary science, and animal welfare, and could be farmers, veterinarians, animal welfare experts.
The Board and its members will have to represent the views of all stakeholders so will be expected to communicate with them regularly.
The Board's responsibilities will include:
The Board will not be set up as a non departmental public body or arms length body. It will form part of the internal structure of Defra.
Commenting on the announcement, Harvey Locke, President of the British Veterinary Association, said: "The BVA is delighted that both the Advisory Group and Ministers have taken note of the veterinary profession's views in drawing up these plans.
"We said from the outset that genuine responsibility sharing has to be achieved before cost sharing can be discussed and we warned against earlier plans to separate animal health policy from animal welfare policy, as the two are intrinsically linked.
"Animal health and welfare policy issues require expert, scientific input and it will be essential that the new Board includes veterinary representation. We believe that the Board will provide the right mechanism for ensuring decisions are based on sound science.
"The new Board will also have to work closely with the three devolved administrations to ensure that animal health and welfare policies across the UK are joined up and complementary."
Merial is inviting all equine veterinary surgeons that are going to BEVA Congress this year to the launch of updated ProteqFlu, its equine flu vaccine which now includes protection against the latest Clade 2 strains, including Richmond 07.
Speakers at the event include specialist Dr Richard Newton (pictured right), Head of Epidemiology and Disease Surveillance at the Animal Health Trust (AHT), and Dr Romain Paillot Head of Immunology at the AHT. Dr Newton will explain why the inclusion of the Clade 2 strain is so important for horse health, and the equine industry as a whole.
Louise Radford MRCVS from Merial said: "We're all incredibly excited as the event will mark the launch of the UKs first and only fully updated equine flu vaccine that contains both a Clade 1 and Clade 2 antigen. The new ProteqFlu® vaccine fully represents the latest 2014 OIE recommended EIV strains."
The launch is being held at the Hotel Du Vin, Birmingham on Thursday 11 September 2014. Presentations will cover 'A virological and immunological perspective on Clade 2 & EIV', 'How technology makes the difference' and independent vaccine trial results.
The evening starts at 6.30pm and includes dinner and evening entertainment.
To book, contact, Jo Gater-Willats, or Merial Customer Support on 0800 6000123.
The review, announced earlier this year, was recommended to RCVS Council by its Standards Committee following its exploration of the implications of new technologies for both animal health and welfare and veterinary regulation.
The main areas under consideration include the provision of 24-hour emergency cover and the interpretation and application of an animal being under the care of a veterinary surgeon.
The initial stages of this review had been drafted for Standards Committee to consider at its meeting on 9 September, where the outline timetable was also discussed.
Standards Committee Chair Melissa Donald, said: "This is set to become one of our most fundamental reviews of RCVS guidance in recent years.
"Considering the complexity of the issues in question, and their importance to animal owners and the professions alike, it is vital that we allow ourselves enough time to ensure this review is as thorough and comprehensive as possible.
"We have a clear responsibility to seek, understand and, where we can, accommodate the opinions and experiences of as many different people from within and around the professions and the public as possible. I would urge my fellow vets and vet nurses to please find some time to consider these issues very carefully over the coming weeks and months, and to send us their views."
The review will comprise several stages and is expected to take around 12 months to complete. The outline timetable, which may be subject to change, is as follows:
October 2019 – January 2020: six-week Call for Evidence, followed by independent qualitative analysis of all evidence received
February – March: Select Committee-style meetings and independent qualitative analysis of additional evidence gathered [NB this stage is subject to Standards Committee requirements, depending on the evidence gathered.]
April – June: Consider all evidence and draft any new policy
July – August: six-week public consultation on draft policy
September – October: independent review of consultation responses, and production of any proposals for change
November 2020: Finalise any proposals for change and publish any new guidance
To support and promote the various stages of the review the College is also planning a programme of stakeholder engagement, and will also provide regular updates on progress to both Council and the wider profession.
Members of the professions and the public will be able to follow the progress of the review via the RCVS website at: www.rcvs.org.uk/undercare
Avacta has announced the launch of Sensitest, the only UK-specific equine allergy tests that use non-invasive procedures.
The company says that the new range of ELISA tests was developed using native plant allergen species, to reflect the needs of UK and Northern European veterinary surgeons.
Janice Hogg, Avacta senior veterinary director, said: "In the development trials, allergens were selected that showed significant levels of reactivity in horses with clinical signs compatible with allergic disease.
"Whilst many providers of allergy tests are reducing the number of allergens in their panels and providing only a global range of allergens, this research has shown it is vital to include native species of allergenic plants and insects.
"The new ELISA test, which includes allergens such as orchard grass, daisy, dandelion, nettle and horse chestnut, provides UK practitioners with a viable alternative to intradermal testing (IDT). It doesn’t require clipping and has no adverse reactions - ideal for clients who want to avoid this."
Avacta says Sensitest includes panels of allergens that cover the work up of food, respiratory and atopic allergic disease assisting in a more accurate diagnosis, treatment and management options, including allergen-specific immunotherapy.
Janice added: "It is not necessary to withdraw medications (except high dose corticosteroids) for the standardised procedure, which has excellent reproducibility and is not influenced by existing skin pathologies, all of which is really useful when working with equine clients.
"To further assist equine practitioners, especially those faced with non-insured clients, the SENSITEST Equine Screening Test offers a simple positive/negative result to each panel, allowing expansion to the full panels as required to assist with treatment."
For more information contact your Avacta area territory manager, call customer services on 0800 8494 550 or visit www.avactaanimalhealth.com/equineallergy
DG Sanco, the EU Directorate General for Health and Consumers, has launched a worldwide photo competition to mark World Vet Year: 'Vets in your daily life'
Entries need to be photos of a vet (or vets) at work or in any situation which shows the diverse nature of the job. Five winners will win 1000 Euros worth of photographic equipment. The overall winner will win an additional 2000 Euros worth of photographic equipment. All winners will also be given travel and accommodation for the awards ceremonies in Paris and Brussels.
Anyone (except for employees of the European Institutions, and their families) can enter the competition, which closes on 31st March 2011. More details can be found at: www.vetsinyourdailylife.org.
Here's the promotional video for the competition:
The event, which was cancelled last year because of the Covid-19 pandemic, is the first opportunity for the profession to get back together after the past two turbulent years. To mark BEVA’s 60th Birthday, special celebrations are in the pipeline as well as the 13th International Equine Colic Symposium taking place during the event.
BEVA President Lucy Grieve said: "We are all so excited that BEVA Congress is back this year, albeit that it will be a little bit different. You can expect the same event we all know and love but with a few new measures in place to ensure we can all stay safe during these uncertain times. We are also offering a virtual option for those that can’t attend in person, so that no one misses out.”
Congress Committee co-chair Tim Barnett said: “My co-chair Ceri Sherlock and I have been working hard over the past few months to put together a programme that rivals anything we’ve had before. You can expect lectures, discussion and debates on a number of topics including learning from mistakes, working in teams, and a dedicated stream of nursing lectures.”
This year Lucy has selected teamwork as the theme for BEVA Congress 2021, in celebration of the Association’s 60th anniversary. She said: “In modern day veterinary medicine, no one person can satisfactorily deliver all that is required.
“Without a team approach, from vets, nurses, practice managers, farriers and paraprofessionals the potential to maximise the health and welfare of horses cannot be fulfilled.
"This year, we intend to celebrate 60 years of teamwork and how we can do far more to serve our patients as a harmonious team than if we work alone.”
Early bird tickets for BEVA Congress are available from 19th April until 16th August 2021. Tickets provide access to all three lecture halls and exhibition halls as well as the virtual congress hub. They also include a complimentary ticket to the 13th International Equine Colic Symposium.
Early bird BEVA member prices are £499 for vets and £187 for vet nurses for all 3 days (with concessions available for those in their first three years of graduation or on a lower salary). Virtual tickets are £99 for BEVA members.
BEVA has introduced a 'peace of mind' bookings policy to reassure those whose personal situation may change between booking their ticket and the event.
Full details of the BEVA Congress programme will be announced shortly. To find out more and to book your tickets visit http://www.bevacongress.org/
Pfizer has repeated it's call for veterinary practice staff to take part in its Vet Support+ independent, industry-wide survey of employee engagement.
The survey gives practice team members, who are not partners or owners, the chance to have their say about their role and career and the future of the profession. Participants are asked to consider how they feel towards their practice and delve into issues on teamwork and communication, management techniques, personal development opportunities and working environment.
More than 3,000 vet practice staff have already completed the survey, a phenomenal early response which suggests practice employees are keen to have their voices heard. However, the closing date for the survey isn't till Friday 29th July, so if you haven't yet had a chance to do the survey, there is still time.
Pfizer Business Consultant, Vanessa Wilson, has more than 20 years experience helping businesses, teams and individuals achieve their goals. She is not surprised at the significant early response: "Questions on the level of employee engagement and satisfaction come up all the time in the work we do with practices. I'm not surprised that staff are using this opportunity to have their voice heard.
"Once completed, this survey will provide some very useful data and direction for the industry as a whole and I'd like to think it will identify opportunities for both individual career development and practice growth."
All members of staff employed within a practice who have not received a mailing and wish to participate are welcome to respond online. http://www.noesis-mi.com/surveys/employeesurvey/.
Pfizer says the findings, which are expected to be released in the autumn, will deliver a national and regional view of the current employee engagement landscape.
For further information about Vet Support+ Business Services from Pfizer visit www.vetsupportplus.co.uk.